Research Power Inc.

Advancing Patient-Centred Treatment Decisions Through Hematology Engagements in Brazil

Emily Sumarah — Tue, 10 Nov 2026 13:18:15 +0000

Research Power Inc. recently contributed to two hematology engagements in Rio de Janeiro, Brazil, led by Senior Partner Claudine Szpilfogel.

Claudine was invited to facilitate a hematology advisory board focused on understanding the factors that inform treatment decisions in chronic lymphocytic leukemia (CLL). This marked the first time the organizing team engaged an external facilitator, a role traditionally managed by its medical team.

During the same visit, Claudine also presented at the annual Brazilian hematology congress, exploring how clinical data can inform patient-centred treatment decisions, alongside two leading Brazilian hematologists.

Both engagements highlight RPI’s expertise in advisory board facilitation, clinical data interpretation and scientific communication.

The presentation explored four considerations in interpreting clinical research: quality, maturity, consistency and clinical relevance, with a focus on how these inform patient-centred treatment decisions.

Strengthening Scientific and Commercial Communication Through Cross-Functional Training

Emily Sumarah — Tue, 10 Nov 2026 13:15:19 +0000

Research Power Inc. recently delivered an interactive workshop in Zurich, Switzerland, for AstraZeneca’s cross-functional hematology-oncology teams, including Medical, Sales, Market Access and Regulatory professionals.

Focused on optimizing how teams communicate the value of treatments in B-cell malignancies, the workshop built on earlier virtual training sessions and reusable learning resources.

As part of an ongoing learning journey, the session emphasized practical application, helping participants strengthen their scientific and Commercial narratives.

The workshop also explored how teams can connect clinical data, unmet patient needs and treatment benefits into compelling narratives tailored to their audiences.

RPI supports pharmaceutical sales team in strengthening customer conversations

Emily Sumarah — Tue, 20 Oct 2026 08:43:53 +0000

Research Power Inc. recently delivered a two-day training program designed to help a pharmaceutical Sales team strengthen its understanding of clinical data and apply that knowledge in customer conversations.

The program brought together customer profiles, interactive exercises, clinical data interpretation, role-playing and a certification component. These activities gave participants opportunities to explore the information, practice applying what they learned and develop their communication skills.

Together, these activities created opportunities for participants to put their knowledge into practice, work through realistic customer scenarios and build confidence in their communication skills.

Human Rights Remedy Evaluation: Your Voice Matters!

admin — Mon, 21 Sep 2026 21:51:37 +0000

Background

The Human Rights Remedy (also called the Remedy) is a plan to reduce discrimination against people with disabilities in Nova Scotia. The Nova Scotia Department of Opportunities and Social Development (OSD) is leading the work to make the Remedy happen.

Evaluation means finding out what is working well and not working as well with the Remedy. It also means checking to see if the changes are making a difference for people with disabilities. The evaluation of the Remedy is a required part of the changes that are happening. It is being done by a team from Research Power Inc. and Cape Breton University. People with disabilities are also part of the evaluation team.

How To Participate

We want to hear from people about their experiences with the Remedy. This includes:

People with disabilities, especially those that receive support through the Disability Support Program (DSP)
Family members and supporters of people with disabilities
Service providers funded through the DSP
DSP staff

Your feedback will help shape how the Remedy is implemented. There are two ways you can participate in the evaluation.

1. Complete a Survey:

Share your experiences and suggestions for improvement through our online surveys:

Survey for people with disabilities, including Disability Support Program (DSP) participants

Survey for family members and supporters of people with disabilities

Survey for service providers funded through the DSP

Survey for DSP staff

You can complete the survey online or on paper. Click on the survey links above to download and print a paper copy and get instructions on where to send your completed paper survey.

If you need help to complete the survey or submit it, or you have any questions about the survey, please contact us at 1-800-763-8710 or remedy.eval@researchpowerinc.com.

You can complete the surveys until Saturday, November 21, 2026.

2. Register for a Virtual Focus Group:

We will be hosting virtual focus groups between October 15 and November 21, 2026 for:

People with disabilities, including Disability Support Program (DSP) participants
Family members and supporters of people with disabilities
Service providers funded through the DSP
DSP staff

This short video explains what focus groups are and how they work. The focus groups will take place virtually using Zoom. You will need to provide an email address to register.

People with disabilities and family members/supporters will receive a cash honorarium after participating in the focus groups.

We are committed to making participation in the focus groups accessible. Available supports include:

Closed captioning
Plain language materials
Materials provided in advance
Participants can have a support person attend with them
ASL interpretation and other supports available upon request

Click Here to Register for a Virtual Focus Group

See the focus group schedule for DSP Participants and People with Disabilities

RPI supports AstraZeneca in advancing the care of patients living with B-cell malignancies

admin — Fri, 07 Aug 2026 17:52:55 +0000

In July 2026, Research Power Inc. was in London with the AstraZeneca Hem-Oncology UK leadership and Key Account Management team focused on advancing the care of patients living with B-cell malignancies. Over the course of 2 days, RPI worked with the UK team in reviewing and discussing the key data presented at the European Hematology Association Congress meeting in Stockholm, Sweden in June and how the body of evidence and EHA Guideline recommendations can inform best patient care in clinical practice with a focus on CLL. Through a series of presentations and workshops, the UK Team left feeling invigorated and equipped to elevate customer conversations and enhance the care of patients living with CLL.

RPI selected as independent evaluator for Human Rights Remedy

admin — Mon, 09 Feb 2026 18:53:00 +0000

RPI is very pleased to share that we have been selected as the independent evaluator for the Nova Scotia Human Rights Remedy. The evaluation team is a partnership between RPI and Cape Breton University.

The Nova Scotia Human Rights Remedy is a five-year, legally binding agreement that guides government’s work to transform the disability support system in Nova Scotia. It is called “the Remedy” because it is what government must do to remedy the discrimination against people with disabilities in Nova Scotia.

Evaluation planning is taking place throughout the first half of 2026, followed by regular evaluation data collection and reporting through to 2029. The evaluation work is guided by an Evaluation Advisory Committee and funded by the Department of Opportunities and Social Development.

Evaluation of the Community Pharmacy Primary Care Clinics

admin — Tue, 01 Apr 2025 17:55:00 +0000

RPI was pleased to be the external evaluator on this important project by the Pharmacy Association of Nova Scotia to improve access to primary care in Nova Scotia. The evaluation found that patients are highly satisfied with their care at the Community Pharmacy Primary Care Clinics (CPPCC), and the clinics successfully diverted patients from emergency departments and walk-in clinics.

Read the press release

Read the evaluation report

Final Evaluation of the UpLift Partnership: Catalyzing a Healthier Nova Scotia through a Youth Engaged Health Promoting Schools Approach

admin — Fri, 14 Mar 2025 17:59:00 +0000

RPI, led by Stephanie Heath was pleased to be the independent evaluator for the UpLift Partnership, an important project advancing health and learning in Nova Scotia.

For six years, the UpLift Partnership brought partners together to collaborate to shift systems for healthy learning environments in Nova Scotia. Through UpLift’s collective actions, new ways to engage and support youth to create healthier school environments for long-term impact were prototyped. With a deep focus on evaluating these methods, these practices were successfully embedded into the health and education system across the province.

The evaluation findings are available on the UpLift website: https://www.upliftns.ca/

College of Family Physicians of Canada (CFPC) releases their research guidance report, developed with RPI support

admin — Fri, 31 May 2024 18:02:00 +0000

The College of Family Physicians of Canada (CFPC) has released its research guidance report titled Advancing Family Medicine Research in Canada: A Guidance Report for the CFPC’s Future Role and Action. This report was developed in collaboration with Research Power Inc. (RPI) and Dalhousie Family Medicine.

Research Power Inc. played a key role in this project by conducting extensive consultations and research, which included:

Interviews, consultation sessions, and surveys with groups and individuals involved in or connected to family medicine research, such as family medicine research leaders, CFPC Chapters, departments of family medicine across Canada, research organizations, government entities, CFPC members, CFPC staff and Board members, and learners and early career researchers.
An environmental scan that involved a review of related grey and academic literature and interviews with expert key informants from other jurisdictions.

The report outlines specific roles and concrete actions the CFPC can take to champion family medicine research. It also provides strategies to support family medicine research in addressing the pressing challenges faced by the discipline. This guidance will steer the CFPC’s future efforts in advancing family medicine research across Canada.